In this comprehensive review, we provide a thorough summary of the current literature concerning the utilization of radiolabeled EGFR- and integrin αVβ3-targeting peptides in cancer imaging and peptide receptor radionuclide therapy (PRRT). This evidence concerns the gene EGFR and cancer.